Afinitor

(everolimus)
everolimus 10 MG Oral Tablet [Afinitor]everolimus 2 MG Tablet for Oral Suspension [Afinitor]
View 5 more
NO BLACK BOX WARNING

Dosage & administration

Do not combine AFINITOR and AFINITOR DISPERZ to achieve the total daily dose.

Modify the dose for patients with hepatic impairment or for patients taking drugs that inhibit or induce P-glycoprotein (P-gp) and CYP3A4.


Breast Cancer:

NET:


RCC:


TSC-Associated Renal Angiomyolipoma:


TSC-Associated SEGA:


TSC-Associated Partial-Onset Seizures:


Most viewed Afinitor resources

Enroll in patient savings program - Oncology Indications

drug label

Afinitor prescribing information

Have more Afinitor questions?

Submit MSL Request
Learn More

Need to report an Afinitor issue?

ONLINE FORM
Report adverse event
Learn More

samples

Request Afinitor samples

NOT PROVIDED BY BRAND
View Online Sample Form
Learn More

prior authorization

Afinitor Prior authorization resources

NOT PROVIDED BY BRAND
Complete Letter of Medical Necessity

NOT PROVIDED BY BRAND
Coverage Authorization Request

NOT PROVIDED BY BRAND
Complete Coverage Authorization appeals

NOT PROVIDED BY BRAND
Coverage Authorization Appeal
Learn More

Benefits investigation

NOT PROVIDED BY BRAND
Benefits investigation resources
Learn More

Reimbursement help (FRM)

NOT PROVIDED BY BRAND
Reimbursement help (FRM) resources
Learn More

financial assistance

Afinitor Financial assistance options

Co-pay savings program

commercial only
Enroll in patient savings program - Oncology Indications
Learn More

Bridge program

commercial only
Learn More

Foundation programs

under insured
no insurance
goverment insurance
65+
Learn More

patient education

Afinitor Patient education

Getting started on Afinitor

NOT PROVIDED BY BRAND
Instructions For Use - Seizure with Tuberous Sclerosis Complex

NOT PROVIDED BY BRAND
Instructions For Use - SEGA with Tuberous Sclerosis Complex

NOT PROVIDED BY BRAND
Instructions For Use - Renal Angiomyolipoma with Tuberous Sclerosis Complex

NOT PROVIDED BY BRAND
Instructions for Use - Advanced HR+, HER-2 Negative Breast Cancer

NOT PROVIDED BY BRAND
Instructions For Use - Advanced Renal Cell Carcinoma

NOT PROVIDED BY BRAND
Instructions For Use - Advanced Pancreatic Neuroendocrine Tumor (NET)

NOT PROVIDED BY BRAND
Instructions For Use - Progressive Nonfunctional GI and Lung Neuroendocrine Tumors (NET)

Patient toolkit

NOT PROVIDED BY BRAND
Not Provided By Brand
Learn More

Can't find what you're looking for?

Our trained staff can help you:
Please note:
  • Access to a Field Reimbursement Manager (FRM) or Medical Science Liaison (MSL) varies by brand and may require talking with your rep first.
  • Samples are provided at the discretion of the brand.
  • We are unable to collect Protected Health Information (PHI), fill out forms, or submit them on your behalf.